publication date: Aug. 3, 2010
In this issue: NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial. The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation. Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say. Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.